To hear about similar clinical trials, please enter your email below
Trial Title:
Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials
NCT ID:
NCT05769491
Condition:
Triple Negative Breast Cancer
Breast Cancer
Conditions: Official terms:
Breast Neoplasms
Triple Negative Breast Neoplasms
Conditions: Keywords:
triple negative breast cancer
breast cancer
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Clinical trials can sometimes favor certain demographic groups. Additionally, there is
limited research that delves into the factors that influence participation in clinical
trials, both positive and negative.
The goal is to identify the obstacles and challenges that prevent participation in Triple
Negative Breast Cancer clinical trials, as well as the reasons for withdrawal or
discontinuation.
The insights gained from this study will ultimately benefit those with Triple Negative
Breast Cancer who may be invited to participate in clinical research in the years to
come.
Criteria for eligibility:
Study pop:
Triple negative breast cancer patients who are actively considering participating in an
observational medical study, but have not yet completed enrollment and randomization.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Age ≥ 18 years
- Willing and able to comply with scheduled visits, treatment schedule, laboratory
tests and other requirements of the study.
- Capable of giving signed informed consent, which includes compliance with
requirements and restrictions listed in the informed consent form (ICF) and in the
protocol
Exclusion Criteria:
- Pregnant or lactating woman
- Any mental or medical condition that prevents the patient from giving informed
consent or participating in the trial
- Inability to perform regular electronic reporting
Gender:
Female
Gender based:
Yes
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
April 2024
Completion date:
April 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05769491
